GMP Audits and Pharmacopoeias: Defending USP vs. Ph. Eur. Decisions (QA/QC)
What FDA/EMA inspectors ask about USP/Ph. Eur. divergences and which evidence is required: dossiers, tables, risk assessments, comparability data, and response scripts.
Read the article →